News and Trends 12 Sep 2022
First patient enrolled in phase 3 study of drug for Charcot-Marie-Tooth disease
The first patient has been enrolled in a phase 3 study of a treatment for type 1A Charcot-Marie-Tooth Disease (CMT1A) in the U.S., it was announced today (September 12). Charcot-Marie-Tooth…